This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's third-quarter performance.
Should You Retain Intercontinental (ICE) in Your Portfolio?
by Zacks Equity Research
Intercontinental Exchange (ICE) stands to gain from strength in the pricing and analytics business, accelerated digitization and a compelling portfolio.
Here's Why Hold is an Apt Strategy for Cboe Global (CBOE) Now
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products and solid capital position poise Cboe Global (CBOE) well for growth.
Why Should You Stay Invested in Cboe Global (CBOE) Stock
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products, solid capital position poise Cboe Global (CBOE) well for growth.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges to Gain From Increased Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Cboe Global (CBOE) Rewards Shareholders With 4.2% Dividend Hike
by Zacks Equity Research
Cboe Global's (CBOE) 4.2% dividend hike reflects its intention to enhance shareholder value, supported by its strong financial position.
Cboe Global (CBOE) Q2 Earnings Miss, Revenues Beat, View Up
by Zacks Equity Research
Cboe Global (CBOE) Q2 results reflect an increase in clearing fees and access and capacity fees, growth in European equities and clearing, and higher net transaction and clearing fees.
CBOE Global (CBOE) Q2 Earnings Miss Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of -1.76% and 0.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Coinbase's SEC Problem is a Good Thing
by David Bartosiak
Should investors stay in Coinbase (COIN) despite the SEC investigation?
OTC Markets Group Inc. (OTCM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cboe Global (CBOE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cboe Global's (CBOE) Q2 results are likely to reflect higher access fees in the Europe and Asia Pacific segment, greater financial risk analytics market data and growth in multi-listed options trading.
CBOE (CBOE) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
CBOE (CBOE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CBOE Global (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Beats on Q2 Earnings, Tightens Expense View
by Zacks Equity Research
Nasdaq (NDAQ) Q2 earnings reflect solid performance of both segments.
Here's Why CBOE Global (CBOE) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does CBOE Global (CBOE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights include AMN Healthcare Services, Otter Tail, Encore Capital Group and Cboe Global Markets
by Zacks Equity Research
AMN Healthcare Services, Otter Tail, Encore Capital Group and Cboe Global Markets are part of zacks Screen of the week article.
4 Stocks Trading Near 52-Week High That Can Scale Higher
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like AMN, OTTR, ECPG and CBOE that are seeing price strength have a high chance of carrying the momentum forward.
3 Reasons Growth Investors Will Love CBOE (CBOE)
by Zacks Equity Research
CBOE (CBOE) could produce exceptional returns because of its solid growth attributes.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why You Should Stay Invested in Cboe Global (CBOE) Stock
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products and solid capital position poise Cboe Global (CBOE) well for growth.
Cboe Global (CBOE) Inks Deal With Validus to Create Indices
by Zacks Equity Research
Cboe Global (CBOE) signs an agreement with Validus to develop new indexes and products.
Why CBOE Global (CBOE) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Hold is an Apt Strategy for Cboe Global (CBOE) Stock Now
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products, solid capital position poise Cboe Global (CBOE) well for growth.
Why CBOE Global (CBOE) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.